About Novartis Oncology
Novartis Oncology in the United States
About Novartis Oncology United States
Novartis Oncology strives to become the world's premier oncology company by consistently discovering, developing and making broadly available novel therapies that may improve and extend the lives of people living with cancer. The main office in the United States is in Florham Park, New Jersey. Formed in 2000, Novartis Oncology is one of the fastest growing of the world's top 5 oncology companies.
Supporting oncology healthcare professionals starts with a broad understanding that cancer is a complex group of diseases fueled by many underlying mechanisms. Research and development at Novartis is built on recent discoveries in molecular genomics, rational drug design and state-of-the-art drug discovery technologies. To support these efforts, the company makes considerable investments in technologies and expertise both internally and externally.
The robust R&D program has enabled Novartis to offer a broad range of innovative therapies to help physicians meet patient needs, - Gleevec® (imatinib mesylate) tablets, Femara® (letrozole tablets), Zometa® (zoledronic acid) Injection, Sandostatin LAR® Depot (octreotide acetate for injectable suspension), Proleukin® (aldesleukin) for injection therapy, Exjade® (deferasirox) and Tasigna® (nilotinib) tablets. Leading the industry in growth, Novartis also has one of the broadest and deepest oncology pipelines in the industry.
In addition to its key therapeutics, Novartis advances the treatment and care of cancer through unprecedented levels of product support and financial assistance for patients. Novartis Oncology seeks to build successful partnerships by identifying areas of collaboration to benefit the cancer patient. By partnering with members of the oncology community, Novartis effectively expands research and development as well as promotes patient education and disease awareness. The company is devoted to developing and maintaining a sensitive understanding of the needs of healthcare professionals and patients. Ultimately, these efforts are intended to help health professionals accomplish their primary goal of improving patient lives.
For more information, visit the Novartis Oncology US site
Contact Information
Customer Interaction Center
Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, NJ 07936-1080
1-888-669-6682
SEARCH OUR WEBSITES
PRODUCTS
At Novartis Oncology, we strive to provide a broad range of innovative, practical solutions and authoritative resource therapies.
CAREERS AT NOVARTIS
Our success depends entirely on the creativity, performance and achievement of our associates at all levels.
RESEARCH INNOVATION
Novartis maintains the most promising oncology drug pipeline in the industry to treat and help people around the world.